Yimin Li

1996–2026 年に発表

245
論文数
28,127
被引用数
68
h 指数
193
i10 指数

被引用数

Yimin Li の年別被引用数1982 年: 被引用 1 件1991 年: 被引用 1 件1999 年: 被引用 1 件2001 年: 被引用 3 件2002 年: 被引用 1 件2003 年: 被引用 1 件2004 年: 被引用 1 件2005 年: 被引用 3 件2007 年: 被引用 4 件2008 年: 被引用 2 件2009 年: 被引用 9 件2010 年: 被引用 15 件2011 年: 被引用 25 件2012 年: 被引用 32 件2013 年: 被引用 40 件2014 年: 被引用 45 件2015 年: 被引用 49 件2016 年: 被引用 52 件2017 年: 被引用 78 件2018 年: 被引用 81 件2019 年: 被引用 222 件2020 年: 被引用 2,749 件2021 年: 被引用 2,437 件2022 年: 被引用 1,210 件2023 年: 被引用 698 件2024 年: 被引用 922 件2025 年: 被引用 479 件2026 年: 被引用 34 件1983〜1990 年は被引用が無いため表示していません1992〜1998 年は被引用が無いため表示していません2000 年は被引用が無いため表示していません2006 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図中国: 引用元論文 2,684 件、この内訳の 19.9%アメリカ合衆国: 引用元論文 2,174 件、この内訳の 16.1%イギリス: 引用元論文 779 件、この内訳の 5.8%イタリア: 引用元論文 604 件、この内訳の 4.5%インド: 引用元論文 591 件、この内訳の 4.4%ドイツ: 引用元論文 418 件、この内訳の 3.1%スペイン: 引用元論文 378 件、この内訳の 2.8%カナダ: 引用元論文 371 件、この内訳の 2.8%フランス: 引用元論文 358 件、この内訳の 2.7%オーストラリア: 引用元論文 310 件、この内訳の 2.3%イラン: 引用元論文 298 件、この内訳の 2.2%ブラジル: 引用元論文 235 件、この内訳の 1.7%
0%19.9%その他 31.7%

分野

  • Medicine64.7%
  • Biochemistry, Genetics and Molecular Biology10.2%
  • Mathematics5.7%
  • Engineering4.8%
  • Computer Science3.5%
  • Immunology and Microbiology2.6%
  • その他8.5%

トピック

  • COVID-19 Clinical Research Studies12.6%
  • SARS-CoV-2 and COVID-19 Research7.5%
  • Long-Term Effects of COVID-195.5%
  • COVID-19 epidemiological studies3.1%
  • COVID-19 and healthcare impacts2.4%
  • COVID-19 diagnosis using AI2.2%
  • その他66.7%

共著者

全論文

検索で開く
  1. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target

    著者: , , , , - Intensive Care Medicine 2020 被引用: 2,822

  2. Modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventions

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Thoracic Disease 2020 被引用: 1,502

  3. Downregulation of MEIS1 mediated by ELFN1-AS1/EZH2/DNMT3a axis promotes tumorigenesis and oxaliplatin resistance in colorectal cancer

    著者: , , , , , , , , , , , , , , - Signal Transduction and Targeted Therapy 2022 被引用: 151

  4. Exuberant fibroblast activity compromises lung function via ADAMTS4

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gwenn E. McLaughlin, Matthew L. Paden, Keiko M. Tarquinio, Bria M. Coates, Neethi Pinto, Juliane Bubeck Wardenburg, Adrienne G. Randolph, Anna A. Agan, Tanya Novak, Margaret M. Newhams, Stephen C. Kurachek, Mary E. Hartman, Allan Doctor, Edward J. Truemper, Sidharth Mahapatra, Kate G. Ackerman, L. Eugene Daugherty, Mark W. Hall, Neal J. Thomas, Scott L. Weiss, Julie C. Fitzgerald, Renee A. Higgerson, Laura L. Loftis, Rainer Gedeit, Marc-André Dugas, Thomas N. Wight, Stacey Schultz‐Cherry, Stephania A. Cormier, Kathryn Shaw‐Saliba, Andrew Pekosz, Richard E. Rothman, Kuan‐Fu Chen, Zifeng Yang, Richard J. Webby, Nanshan Zhong, Jeremy Chase Crawford, Paul G. Thomas - Nature 2020 被引用: 226

  5. Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19

    著者: , , , , , , , , , , , , , , , , , , , - JAMA Internal Medicine 2020 被引用: 1,519

  6. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2010 被引用: 802

  7. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peng Peng, Jian Ming Wang, Jiyang Liu, Zhong Chen, Gang Li, Zhi-jian Zheng, Shao-qin Qiu, Jie Luo, Chang-jiang Ye, Shao-yong Zhu, Lin-ling Cheng, Feng Ye, Shi-yue Li, Jin-ping Zheng, Nuo-fu Zhang, Nanshan Zhong, Jian-xing He - European Respiratory Journal 2020 被引用: 3,771

  8. Emerging mechanisms of lipid peroxidation in regulated cell death and its physiological implications

    著者: , , , , - Cell Death and Disease 2024 被引用: 240

  9. Ferroptosis, pyroptosis and necroptosis in acute respiratory distress syndrome

    著者: , , , , , - Cell Death Discovery 2023 被引用: 63

  10. Cloud-Edge Collaborative SFC Mapping for Industrial IoT Using Deep Reinforcement Learning

    著者: , , , , , - IEEE Transactions on Industrial Informatics, IEEE Trans. Ind. Informatics 2021 被引用: 62

  11. Guidelines for the diagnosis, treatment, prevention and control of infections caused by carbapenem-resistant gram-negative bacilli

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yunsong Yu, Minggui Wang - Journal of Microbiology Immunology and Infection 2023 被引用: 134

  12. Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mariah Leidinger, Jiekai Chen, Yimin Li, Nanshan Zhong, David K. Meyerholz, Paul B. McCray, Stanley Perlman, Jincun Zhao, Jincun Zhao - Cell 2020 被引用: 494

  13. Long-Term Efficacy of a Hepatitis E Vaccine

    著者: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2015 被引用: 373

  14. Intracellular and Extracellular Lipopolysaccharide Signaling in Sepsis: Avenues for Novel Therapeutic Strategies

    著者: , , , , , - Journal of Innate Immunity 2021 被引用: 142

  15. Modulating the Tumor Microenvironment via Oncolytic Viruses and CSF-1R Inhibition Synergistically Enhances Anti-PD-1 Immunotherapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Molecular Therapy 2018 被引用: 114

  16. Efficacy, safety, and immunogenicity of an Escherichia coli-produced Human Papillomavirus (16 and 18) L1 virus-like-particle vaccine: end-of-study analysis of a phase 3, double-blind, randomised, controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Qiu-Fen Zhang, Guang Sun, Fengcai Zhu, Shaowei Li, Yimin Li, Huirong Pan, Jun Zhang, You‐Lin Qiao, Ningshao Xia - The Lancet Infectious Diseases 2022 被引用: 89

  17. Activation of CncC pathway by ROS burst regulates cytochrome P450 CYP6AB12 responsible for λ-cyhalothrin tolerance in Spodoptera litura

    著者: , , , , , - Journal of Hazardous Materials 2019 被引用: 128

  18. Early triage of critically ill COVID-19 patients using deep learning

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nanshan Zhong, Junzhou Huang, Jianxing He - Nature Communications 2020 被引用: 304

  19. Efficacy, Safety, and Immunogenicity of an Escherichia coli-Produced Bivalent Human Papillomavirus Vaccine: An Interim Analysis of a Randomized Clinical Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Guo-Qi Gao, Ba-Yi Li, Bin Zhao, Fengxian Zheng, Cui-Hong Dai, Meng Guo, Jun Zhao, Yingying Su, Junzhi Wang, Fengcai Zhu, Shaowei Li, Huirong Pan, Yimin Li, Jun Zhang, Ningshao Xia - JNCI Journal of the National Cancer Institute 2019 被引用: 179

  20. Traditional Chinese medicine formulas for the treatment of osteoporosis: Implication for antiosteoporotic drug discovery

    著者: , , , , , , , , , - Journal of Ethnopharmacology 2016 被引用: 246

  21. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jun Lin, Yun Ling, Haofei Liu, Jianwei Liu, Nianping Liu, Shu‐Qiang Liu, Meng Luo, Qiang Ma, Song Qibing, Wujianan Sun, Gaoxiang Wang, Feng Wang, Ying Wang, Xiaofeng Wen, Qian Wu, Gang Xu, Xiaowei Xie, Xinxin Xiong, Xudong Xing, Hao Xu, Chonghai Yin, Dongdong Yu, Kezhuo Yu, Jinbo Yuan, Biao Zhang, Peipei Zhang, Tong Zhang, Jincun Zhao, Peidong Zhao, Peidong Zhao, Wei Zhou, Wei Zhou, Xiaosong Zhong, Shuye Zhang, Shuye Zhang, Ping Zhu, Bin Zou, Jiahua Zou, Jiahua Zou, Zengtao Zuo, Fan Bai, Xi Huang, Penghui Zhou, Qinghua Jiang, Zhiwei Huang, Lai Wei, Lai Wei, Xiu-Wu Bian, Xindong Liu, Tao Cheng, Xiangpan Li, Pingsen Zhao, Pingsen Zhao, Fang Wang, H Wang, Kun Qu, Zheng Zhang, Kun Qu, Xiaoqun Wang, Jiekai Chen, Ronghua Jin, Zemin Zhang - Cell 2021 被引用: 194

  22. Single-cell sequencing identifies differentiation-related markers for molecular classification and recurrence prediction of PitNET

    著者: , , , , , , , , , , , , , , , , , , , , - Cell Reports Medicine 2023 被引用: 67

  23. The metabolic resistance of Nilaparvata lugens to chlorpyrifos is mainly driven by the carboxylesterase CarE17

    著者: , , , - Ecotoxicology and Environmental Safety 2022 被引用: 40

  24. Kinetics of viral load and antibody response in relation to COVID-19 severity

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Huibin Lv, Yongliang Jiang, Min Li, Yimin Lin, Ying Deng, Lan Tang, Jieling Liang, Jicheng Huang, Stanley Perlman, Nanshan Zhong, Jingxian Zhao, Malik Peiris, Yimin Li, Jincun Zhao - Journal of Clinical Investigation 2020 被引用: 602